These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32922434)

  • 1. ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer.
    Liang X; Gao J; Wang Q; Hou S; Wu C
    Front Genet; 2020; 11():846. PubMed ID: 32922434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation.
    Guan Z; Sun Y; Mu L; Jiang Y; Fan J
    BMC Cancer; 2022 Mar; 22(1):240. PubMed ID: 35246056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircACTR2 promotes bladder cancer progression through IKBKB-mediated NF-κB signaling pathway activation.
    Li P; Zhao Z; Chen Q; Liu Y; Sun G; Chen J; Jia R; Ge J
    Heliyon; 2024 Jun; 10(11):e30778. PubMed ID: 38882353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma.
    Li L; Li X; Wang W; Gao T; Shi Z
    Biomed Pharmacother; 2018 Feb; 98():201-206. PubMed ID: 29268240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.
    Xu T; Zhang R; Dong M; Zhang Z; Li H; Zhan C; Li X
    Onco Targets Ther; 2019; 12():10639-10650. PubMed ID: 31824171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
    Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
    Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma.
    Ge S; Xu Y; Wang H; Sun Y; Tian X; Cao Z; Lin X; Xu J; Wang Q
    Oncol Lett; 2017 Sep; 14(3):3689-3696. PubMed ID: 28927132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A.
    Wang X; Meng R; Hu QM
    Front Genet; 2020; 11():180. PubMed ID: 32194636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer-related gene 4 inhibits gastric cancer growth and metastasis by upregulating Krüppel-like factor 2 expression.
    Li X; Hu S; Ma M; Wang P; Qi Y; Zhou Y; Zhong Z; Gao H; Bai F
    Ann Transl Med; 2023 Feb; 11(4):176. PubMed ID: 36923086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
    Int J Oncol; 2016 Jan; 48(1):225-34. PubMed ID: 26647959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4.
    Qin W; Zhang J; Rong R; Zhang L; Gao H; Liu C; Ren Q; Zheng G; Wang J; Meng L; Qiao S; Qian R; Zhou C; Wang H; Zhang Y
    Tissue Cell; 2022 Oct; 78():101867. PubMed ID: 35908351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling.
    Tian H; Wang X; Lu J; Tian W; Chen P
    Chem Biol Interact; 2019 Aug; 308():244-251. PubMed ID: 31145890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.
    Mei Y; Du Z; Hu C; Greenwald NF; Abedalthagafi M; Agar NYR; Dunn GP; Bi WL; Santagata S; Dunn IF
    Cell Commun Signal; 2017 Sep; 15(1):34. PubMed ID: 28923059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer.
    Cheng C; Song D; Wu Y; Liu B
    Front Mol Biosci; 2020; 7():218. PubMed ID: 33062641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.